To investigate the effect of the HER2/CEP17 ratio on pCR, we first used a simple logistic regression model, in which the effects of patient age, menopausal status, treatment arm, HER2/CEP17 ratio, and other tumor-biological variables were evaluated with respect to the dependent outcome variable pCR. The gene discussed is ERBB2; the disease is neoplasm.